Chemoinformaics analysis of 4-Methoxy-9,10-dihydrophenanthrene-2,7-diol
Molecular Weight | 242.274 | nRot | 1 |
Heavy Atom Molecular Weight | 228.162 | nRig | 16 |
Exact Molecular Weight | 242.094 | nRing | 3 |
Solubility: LogS | -3.372 | nHRing | 0 |
Solubility: LogP | 3.066 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
nHA | 3 | APOL | 36.7911 |
nHD | 2 | BPOL | 15.7809 |
QED | 0.808 |
Synth | 2.271 |
Natural Product Likeliness | 1.48 |
NR-PPAR-gamma | 0.612 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.054 |
Pgp-sub | 0.193 |
HIA | 0.005 |
CACO-2 | -4.82 |
MDCK | 0.0000148 |
BBB | 0.205 |
PPB | 0.876569 |
VDSS | 1.249 |
FU | 0.0526756 |
CYP1A2-inh | 0.968 |
CYP1A2-sub | 0.907 |
CYP2c19-inh | 0.668 |
CYP2c19-sub | 0.08 |
CYP2c9-inh | 0.299 |
CYP2c9-sub | 0.948 |
CYP2d6-inh | 0.921 |
CYP2d6-sub | 0.93 |
CYP3a4-inh | 0.869 |
CYP3a4-sub | 0.204 |
CL | 11.846 |
T12 | 0.708 |
hERG | 0.133 |
Ames | 0.408 |
ROA | 0.115 |
SkinSen | 0.839 |
Carcinogencity | 0.065 |
EI | 0.929 |
Respiratory | 0.292 |
NR-Aromatase | 0.534 |
Antiviral | No |
Prediction | 0.548567 |